A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa® device

Indian Journal of Anaesthesia

Volumn 56, Issue 6, 2012, Pages 518-523

  Misra, Satyajeet ^a   Koshy, Thomas ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Anaesthetic conserving device; ICU sedation; Isoflurane; Midazolam; Propofol; Sevoflurane

Indexed keywords

ANESTHETIC GAS; DESFLURANE; DEXMEDETOMIDINE; ETOMIDATE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MIDAZOLAM; PROPOFOL; SEVOFLURANE; SUFENTANIL; TROPONIN T;

ABSENCE OF SIDE EFFECTS; ADRENAL SUPPRESSION; ANESTHESIA LEVEL; ANESTHETIC EQUIPMENT; ANESTHETIC RECOVERY; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL TRIAL (TOPIC); DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; EXTUBATION; HEART FAILURE; HUMAN; HYPOTENSION; INFECTION RISK; INTENSIVE CARE UNIT; KIDNEY FAILURE; METABOLIC ACIDOSIS; MINIMUM LUNG ALVEOLUS CONCENTRATION; PATIENT COMPLIANCE; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SEDATION; SIDE EFFECT; TACHYPHYLAXIS; TRACHEAL SUCTION SET;

EID: 84871419886     PISSN: 00195049     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5049.104565     Document Type: Review

References (33)

1. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: An executive summary. Society of Critical Care Medicine. Crit Care Med 1995;23:1596-600.
2. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41.
3. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med. 2003, 29: 1417-25.
4. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-56.
5. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology 1984;61:647-51.
6. Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the α2-adrenoreceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003;18:29-41.
7. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. SEDCOM (Safety and efficacy of dexmedetomidine compared with midazolam) study group. Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009;301:489-99.
8. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: Theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol 2005;19:523-38.
9. Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986;14:832-3.
10. Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med 2006;32:927-33.
11. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004;61:1254-9.
12. Weber NC, Schlack W. Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol 2008;182:187-207.
13. Kehl F, Payne RS, Roewer N, Schurr A. Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res 2004;1021:76-81.
14. Meiser A, Bellgardt M, Belda J, Röhm K, Laubenthal H, Sirtl C.Technical performance and reflection capacity of the anaesthetic conserving device-a bench study with isoflurane and sevoflurane. J Clin Monit Comput 2009;23:11-9.
15. Thomasson R, Luttropp HH, Werner O. A reflection filter for isoflurane and other anaesthetic vapours. Eur J Anaesthesiol 1989;6:89-94.
16. Perhag L, Reinstrup P, Thomasson R, Werner O. The reflector: A new method for saving anaesthetic vapours. Br J Anaesth 2000;85:482-6.
17. Enlund M, Wiklund L, Lambert H. A new device to reduce the consumption of a halogenated anaesthetic agent. Anaesthesia 2001;56:429-32.
18. Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med 2004;32:2241-6.
19. L'Her E, Dy L, Pili R, Prat G, Tonnelier JM, Lefevre M, et al. Feasibility and potential cost/benefit of routine isoflurane sedation using an anesthetic-conserving device: A prospective observational study. Respir Care 2008;53:1295-303.
20. Behne M, Wilke HJ, Harder S. Clinical pharmacokinetics of sevoflurane. Clin Pharmacokinet 1999;36:13-26.
21. Röhm KD, Wolf MW, Schöllhorn T, Schellhaass A, Boldt J, Piper SN. Short term sevoflurane sedation using the anaesthetic conserving device after cardiothoracic surgery. Intensive Care Med 2008;34:1683-9.
22. Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J, et al. Long-term sedation in intensive care unit: A randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med 2011;37:933-41.
23. Hellström J, öwall A, Bergström J, Sackey PV. Cardiac outcome after sevoflurane versus propofol sedation following coronary bypass surgery: A pilot study. Acta Anaesthesiol Scand 2011;55:460-7.
24. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA 1973;225:1611-6.
25. Röhm KD, Mengistu A, Boldt J, Mayer J, Beck G, Piper SN. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: A comparison with intravenous propofol sedation. Anesth Analg 2009;108:1848-54.
26. Sackey PV, Martling CR, Radell PJ. Three cases of PICU sedation with isoflurane delivered by the 'AnaConDa'. Paediatr Anaesth 2005;15:879-85.
27. Jung C, Granados M, Marsol P, Murat I, Gall O. Use of sevoflurane sedation by the AnaConDa device as an adjunct to extubation in a paediatric burn patient. Burns 2008;34:136-8.
28. Coleman MA, Coles S, Lytle T, Bennetts FE. Prevention of atmospheric contamination during isoflurane sedation. Clin Intensive Care 1994;5:217-20.
29. Sackey PV, Martling CR, Nise G, Radell PJ. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the anesthetic Conserving Device. Crit Care Med 2005;33:585-90.
30. Berton J, Sargentini C, Nguyen JL, Belii A, Beydon L. AnaConDa® reflection filter: Bench and patient evaluation of safety and volatile anesthetic conservation. Anesth Analg 2007;104:130-4.
31. Soukup J, Schärff K, Kubosch K, Pohl C, Bomplitz M, Kompardt J. State of the art: Sedation concepts with volatile anesthetics in critically ill patients. J Crit Care 2009;24:535-44.
32. Tempia A, Olivei MC, Calza E, Lambert H, Scotti L, Orlando E, et al. The anesthetic conserving device compared with conventional circle system used under different flow conditions for inhaled anesthesia. Anesth Analg 2003;96:1056-1061.
33. Nseir S, Makris D, Mathieu D, Durocher A, Marquette CH. Intensive care-unit infection as a side effect of sedation. Crit Care 2010;14:R30.